30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dan Swisher

Track

Insider profile

Currently holds positions in Cerus Corp, Corcept Therapeutics Inc and Jazz Pharmaceuticals PLC

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
10 30% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 51%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Chairman of the Board Cerus Corp Oct. 21, 2013 -
Independent Director Corcept Therapeutics Inc June 1, 2015 -
President, Chief Operating Officer Jazz Pharmaceuticals PLC Jan. 3, 2018 -
President, Chief Executive Officer, Corporate Secretary, Director Sunesis Pharmaceuticals Inc Nov. 30, 2017 - Dec. 31, 2017
President, Chief Executive Officer, Interim Chief Financial Officer, Corporate Secretary Sunesis Pharmaceuticals Inc Jan. 1, 2016 - Nov. 30, 2017
Director Ocugen Inc June 18, 2015 - Jan. 1, 2016
President, Chief Executive Officer, Director Sunesis Pharmaceuticals Inc Aug. 1, 2005 - Jan. 1, 2016
Independent Director Cerus Corp June 27, 2011 - Oct. 21, 2013
Dan Swisher's trades of Corcept Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-15 2025-10-10
PlS Planned sale
77,456 +26.9%
103.04
US$3,515,351 		77,456 +26.9% 103.04 US$3,515,351
2025-10-10 2025-10-10
PrS Proposed sale
23,079
84.00
US$3,919,848 		23,079 84.00 US$3,919,848
2025-09-11 2025-09-10
PlS Planned sale
79,182 -40.0%
341.38
US$3,938,558 		79,182 -40.0% 341.38 US$3,938,558
2025-09-10 2025-09-10
PrS Proposed sale
2,200
72.45
US$159,390 		2,200 72.45 US$159,390
2025-08-12 2025-08-11
PlS Planned sale
2,200 -100.0%
72.30
US$159,060 		2,200 -100.0% 72.30 US$159,060
2025-08-11 2025-08-11
PrS Proposed sale
2,200
72.30
US$159,060 		2,200 72.30 US$159,060
2025-07-14 2025-07-10
PlS Planned sale
2,200 -100.0%
71.08
US$156,376 		2,200 -100.0% 71.08 US$156,376
2025-07-10 2025-07-10
PrS Proposed sale
2,200
71.08
US$156,376 		2,200 71.08 US$156,376
2025-06-12 2025-06-10
PlS Planned sale
2,200 -100.0%
70.61
US$155,342 		2,200 -100.0% 70.61 US$155,342
2025-06-10 2025-06-10
PrS Proposed sale
2,200
70.61
US$155,342 		2,200 70.61 US$155,342
2025-05-14 2025-05-12
PlS Planned sale
400 -100.0%
71.55
US$28,620 		400 -100.0% 71.55 US$28,620
2025-05-14 2025-05-12
PlS Planned sale
1,800 -81.8%
72.17
US$129,906 		1,800 -81.8% 72.17 US$129,906
2025-05-12 2025-05-12
PrS Proposed sale
400
71.55
US$28,620 		400 71.55 US$28,620
2025-05-12 2025-05-12
PrS Proposed sale
1,800
72.17
US$129,906 		1,800 72.17 US$129,906
2025-04-14 2025-04-10
PlS Planned sale
2,200 -100.0%
70.22
US$154,484 		2,200 -100.0% 70.22 US$154,484
2025-04-10 2025-04-10
PrS Proposed sale
2,200
70.22
US$154,484 		2,200 70.22 US$154,484
2025-03-12 2025-03-10
PlS Planned sale
2,200 -100.0%
53.60
US$117,920 		2,200 -100.0% 53.60 US$117,920
2025-03-10 2025-03-10
PrS Proposed sale
2,200
53.60
US$117,920 		2,200 53.60 US$117,920
2025-02-12 2025-02-10
PlS Planned sale
2,200 -100.0%
68.08
US$149,776 		2,200 -100.0% 68.08 US$149,776
2025-02-10 2025-02-10
PrS Proposed sale
2,200
68.08
US$149,776 		2,200 68.08 US$149,776
2025-01-14 2025-01-10
PlS Planned sale
2,200 -100.0%
50.54
US$111,188 		2,200 -100.0% 50.54 US$111,188
2025-01-10 2025-01-10
PrS Proposed sale
2,200
50.54
US$111,188 		2,200 50.54 US$111,188
2024-12-12 2024-12-10
PlS Planned sale
2,200 -100.0%
59.46
US$130,812 		2,200 -100.0% 59.46 US$130,812
2024-12-10 2024-12-10
PrS Proposed sale
2,200
59.46
US$130,812 		2,200 59.46 US$130,812
2024-11-13 2024-11-11
PlS Planned sale
2,200 -100.0%
59.88
US$131,736 		2,200 -100.0% 59.88 US$131,736
2024-11-12 2024-11-11
PrS Proposed sale
2,200
59.88
US$131,736 		2,200 59.88 US$131,736
2024-08-05 2024-08-01
PlS Planned sale
150 -100.0%
38.50
US$5,775 		150 -100.0% 38.50 US$5,775
2024-08-01 2024-08-01
PrS Proposed sale
150
38.50
US$5,775 		150 38.50 US$5,775
2024-07-03 2024-07-01
PlS Planned sale
2,200 -100.0%
32.81
US$72,182 		2,200 -100.0% 32.81 US$72,182
2024-07-01 2024-07-01
PrS Proposed sale
2,200
32.81
US$72,182 		2,200 32.81 US$72,182
2024-06-05 2024-06-03
PlS Planned sale
2,200 -100.0%
30.21
US$66,462 		2,200 -100.0% 30.21 US$66,462
2024-06-03 2024-06-03
PrS Proposed sale
2,200
30.21
US$66,462 		2,200 30.21 US$66,462
2024-05-09 2024-05-09
US Cerus Corp (CERS)
B Purchase
2,500 +2.4%
1.88
US$4,689 		2,500 +2.4% 1.88 US$4,689
2024-05-03 2024-05-01
PlS Planned sale
2,200 -100.0%
23.09
US$50,798 		2,200 -100.0% 23.09 US$50,798
2024-05-03 2024-05-01
PlS Planned sale
2,200 -100.0%
23.09
US$50,798 		2,200 -100.0% 23.09 US$50,798
2024-05-01 2024-05-01
PrS Proposed sale
2,200
23.09
US$50,798 		2,200 23.09 US$50,798
2024-04-03 2024-04-01
PlS Planned sale
2,200 -100.0%
25.30
US$55,660 		2,200 -100.0% 25.30 US$55,660
2024-04-01 2024-04-01
PrS Proposed sale
2,200
25.30
US$55,660 		2,200 25.30 US$55,660
2024-03-05 2024-03-01
PlS Planned sale
2,200 -100.0%
23.59
US$51,898 		2,200 -100.0% 23.59 US$51,898
2024-03-01 2024-03-01
PrS Proposed sale
2,200
23.59
US$51,898 		2,200 23.59 US$51,898
2024-02-02 2024-02-01
PlS Planned sale
2,200 -100.0%
22.00
US$48,400 		2,200 -100.0% 22.00 US$48,400
2024-02-01 2024-02-01
PrS Proposed sale
2,200
22.00
US$48,400 		2,200 22.00 US$48,400
2024-01-04 2024-01-02
PlS Planned sale
2,200 -100.0%
22.11
US$48,642 		2,200 -100.0% 22.11 US$48,642
2024-01-02 2024-01-02
PrS Proposed sale
2,200
22.11
US$48,642 		2,200 22.11 US$48,642
2023-12-05 2023-12-01
PlS Planned sale
2,200 -100.0%
25.47
US$56,034 		2,200 -100.0% 25.47 US$56,034